Emily TurnerHelena Teede's PCOS Announcement: What Every Australian Woman Needs to Know Right Now
Australian professor Helena Teede, one of the world's leading researchers in polycystic ovary syndrome (PCOS), has made a significant announcement in 2026 that is capturing attention from medical professionals and patients across Australia and beyond. Teede, a professor at Monash University and a global authority on women's endocrine health, has been instrumental in shaping international PCOS guidelines — and her latest statement is reshaping how Australian women understand and seek treatment for this common but frequently misdiagnosed condition.
PCOS affects approximately 8 to 13 per cent of women of reproductive age in Australia, according to the Jean Hailes for Women's Health — an estimated 1 in 8 Australian women — yet diagnosis rates remain low and many women wait years before receiving correct care.
What Is the Helena Teede PCOS Announcement?
Professor Helena Teede has long championed improved diagnostic standards for PCOS, most notably through her leadership of the international evidence-based PCOS guidelines, which have been adopted across Australia and in more than 40 countries. Her 2026 announcement builds on this work, with a focus on earlier intervention, improved mental health support for PCOS patients, and expanded recognition of PCOS presentations that fall outside the classic diagnostic profile.
The announcement underscores something advocates have argued for years: PCOS is not simply a fertility problem. It is a complex metabolic and hormonal condition with lifelong health consequences, including elevated risk of type 2 diabetes, cardiovascular disease, endometrial cancer, and mental health conditions including anxiety and depression.
Teede's research and advocacy have consistently highlighted that many women with PCOS are dismissed or receive incomplete diagnoses because their symptoms do not match narrow clinical assumptions — particularly those who are not overweight or who have regular periods but still have polycystic ovaries and elevated androgens.
Symptoms Australians Should Not Ignore
Because PCOS presents differently in different women, many cases are missed for years. The updated international guidelines, developed with Teede's involvement, recommend that any combination of the following warrants a proper medical workup:
Menstrual irregularity: Cycles shorter than 21 days or longer than 35 days, or fewer than eight cycles per year, can indicate ovulatory dysfunction associated with PCOS.
Signs of elevated androgens: Excess facial or body hair (hirsutism), persistent acne in adults, and scalp hair thinning can all be hormone-related.
Polycystic ovarian morphology on ultrasound: The presence of multiple small follicles in the ovaries does not alone confirm PCOS, but in combination with other symptoms it is diagnostically significant.
Metabolic symptoms: Unexplained weight gain, difficulty losing weight, skin darkening around the neck or armpits (acanthosis nigricans), and fatigue may indicate insulin resistance commonly associated with PCOS.
Mental health symptoms — including mood disorders, low self-esteem, and disordered eating — are now recognised as core features of PCOS that require management alongside the physical presentation.
The Diagnosis Gap: Why So Many Australian Women Wait Too Long
Despite PCOS being among the most common endocrine disorders in women of reproductive age, the average time from symptom onset to diagnosis in Australia is estimated at two years or longer. Several barriers contribute to this gap.
GPs may not connect a pattern of symptoms that individually appear unrelated — acne, irregular periods, and fatigue — with a single underlying condition. Women who do not want children may not pursue investigation because they are unaware of the metabolic risks. And the condition's variable presentation means that women whose symptoms are predominantly metabolic may not be recognised as PCOS patients in a standard consultation.
Teede's work emphasises that addressing this diagnostic gap requires systemic change — including better training for GPs, improved patient resources, and greater awareness of non-reproductive PCOS features.
What Treatment Options Are Available in 2026?
PCOS management in 2026 is multidisciplinary and highly individualised. The international guidelines supported by Teede's research recommend a combination of lifestyle intervention, pharmacological management, and psychological support — with treatment goals tailored to the individual's primary concerns.
Lifestyle interventions — including evidence-based dietary changes and structured exercise — remain first-line treatment for most women because of their impact on insulin sensitivity and weight management. Even modest weight loss of five to ten per cent in women with BMI over 25 has been shown to significantly restore ovulatory function and reduce metabolic risk.
For menstrual irregularities and androgen excess, hormonal contraceptives — particularly the oral contraceptive pill — are commonly prescribed. For women seeking pregnancy, ovulation induction with letrozole or clomiphene citrate is recommended as first-line pharmacological treatment under the updated guidelines. Metformin continues to be used for its insulin-sensitising effects, particularly in women with significant metabolic dysfunction.
Psychological care — including cognitive behavioural therapy for depression and anxiety — is explicitly recommended in the international guidelines as a core treatment component, not an optional add-on.
When Should You Consult a Specialist?
Many Australian women first raise PCOS concerns with their GP, which is the appropriate starting point. However, referral to a specialist is often warranted in the following situations:
- Persistent symptoms not adequately managed after initial GP treatment
- Difficulty conceiving despite attempts over 12 months (or six months if over 35)
- Severe mental health symptoms linked to PCOS
- Metabolic concerns including prediabetes or elevated cholesterol
- Uncertainty about diagnosis where multiple conditions may be present
An endocrinologist, gynaecologist, or reproductive endocrinologist can provide comprehensive management. Dietitians with women's health expertise and psychologists familiar with chronic condition management are valuable members of a multidisciplinary care team.
ExpertZoom connects Australian women with certified medical specialists who understand complex conditions like PCOS, reducing the search time between symptom onset and finding the right care.
Helena Teede's Broader Legacy in Australian Women's Health
Professor Teede's contribution to PCOS awareness and management extends beyond any single announcement. Her leadership has produced internationally recognised clinical guidelines, improved diagnostic standards, and elevated the conversation about women's endocrine health at the highest levels of Australian and global medicine.
For Australian women living with PCOS, the most important takeaway from Teede's ongoing advocacy is simple: you deserve a thorough, evidence-based assessment — and if your current care is not addressing all dimensions of your condition, a second opinion or specialist referral is entirely appropriate.
This article is for general informational purposes only and does not constitute medical advice. Please consult a qualified healthcare professional for advice specific to your health situation.
